16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME

Gilead Sciences
ERGOLINE-DERIVED AGONISTS OF THE 5-HT2A RECEPTOR

Diamond Therapeutics Inc.
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS

Theravance Biopharma R&D Ip
Anti-cancer nuclear hormone receptor-targeting compounds

Nuvation Bio
2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same

The Trustees of The University of Pennsylvania
Class of amino-substituted nitrogen-containing fused ring compounds, preparation method therefor, and use thereof

Shanghai Ringene Biopharma
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Ideaya Biosciences
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Array Biopharma
Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from Paulownia tomentosa as active ingredient

Industry-Academic Cooperation Foundation Gyeongsang National University
Substituted imidazopyridazines

Bayer Intellectual Property
Antagonists of prostaglandin EP3 receptor

Pfizer
Inhibitors of beta-secretase

Vitae Pharmaceuticals
Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders

Janssen Pharmaceutica
Substituted imidazo[1,2-a]pyrimidines and —pyridines

Bayer Intellectual Property
(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity

Novartis
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))

Galderma Research & Development